Updates on Antibiotic Drug Resistance the Medical Industry Needs to Hear About — SMi Group
Superbugs and Superdrugs USA 2017
LONDON, England – Oct. 17, 2017 – PRLog — Experts who are paving the way on tackling antibiotic resistance (AMR) will gather when SMi’s next annual Superbugs & Superdrugs USA conference arrives to Iselin, New Jersey in just 4 weeks’ time. Building on over 20 years of success in Europe, the USA event has attracted a truly global audience from Canada, Denmark, France, USA and UK.
With an aim at enabling new drug discovery and research, event highlights will include:
1. New pathways to facilitate research from bench to bedside with a detailed spotlight on the latest government incentives and funding opportunities. Will include a keynote address from John Rex (AstraZeneca)
2. Strategies to address the problem of MDR Gram-negative pathogens through key updates on three new discovery projects.
3. An agenda tailored towards strengthening the antibiotic pipeline with 15+ hours of content on innovations and clinical breakthroughs.
4. International case studies on medical devices and hospital acquired infections, minimising the microbiome’s disruption, immunotherapeutics and innate defense regulators.
5. A look into the link between animal models and humans to improve clinical outcomes.
Further details are available online at https://www.smi-
Superbugs wfv & Superdrugs USA will take place on 13th & 14th November at the Renaissance Woodbrigde Hotel in Iselin, New Jersey. Sponsored by Merck and Soligenix.
— END —
Contact Information:
For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-
